
Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025, on January 30 – February 1, in Paris, France. As well as ten research e-posters, with data that differentiate its aesthetic products, Galderma will host three symposia, five Meet The Expert sessions, and an interactive booth. More details on Galderma’s scientific presentations at IMCAS can be found below. E-posters will be available to view in a digital library onsite in the e-poster Area (Level 2).
First author |
Abstract title |
Presentation type and # |
Neuromodulators |
||
A. Moradi
|
Aesthetic improvement and subject satisfaction with liquid relabotulinumtoxinA treatment of glabellar lines in a 12-month, randomized, controlled trial |
E-poster #145498 |
E. Lekholm |
RelabotulinumtoxinA, a ready-to-use formulation neuromodulator manufactured with PEARL technology to maintain high potency and specific activity |
E-poster #145625 |
M.S. Nestor |
RelabotulinumtoxinA did not induce the formation of neutralizing antibodies across almost 1700 subjects treated in the Phase III Program |
E-poster #145495 |
V. Bertucci
|
Treatment of glabellar lines and lateral canthal lines with RelaBoNT-A across different ethnicity and race: pooled data from three Phase III studies |
E-poster #145494 |
Biostimulators |
||
S. Fabi |
Poly L-lactic acid (Sculptra®): A regenerative aesthetic treatment |
E-poster #145491 |
O. Markowitz |
Evaluation of synergistic effects for midface improvement when pairing Sculptra (PLLA-SCA) with Alastin skincare®: A comparative study |
E-poster #145493 |
A. Haddad |
Comparing poly-l-lactic acid (PLLA-SCA) and calcium hydroxyapatite (CaHA-R) in-vivo |
E-poster #145492 |
L. Avelar |
Comparing two biostimulators on the local tissue response and degradation in-vivo with an indirect comparison to clinical outcomes |
E-poster #145501 |
Fillers |
||
T. Bromée |
A new hyaluronic acid injectable, HA-SHA, sets new G-prime standards |
E-poster #145500 |
A. Nikolis |
Hyaluronic acid fillers preserve natural movement and dynamic expression: data from three Phase IV clinical trials |
E-poster #145499 |